Sanofi Consumer Healthcare India Share Price: What Could the Next 3 Years Look Like?

The Sanofi Consumer Healthcare India share price forecast for the next 3 years is a question on many investors’ minds as the stock trades at Rs 4,601 on 10 July 2026, within a 52 week range of Rs 3,950 to Rs 5,512. This article lays out a scenario based Sanofi Consumer Healthcare India share price outlook for 2027, 2028 and 2030, built on the company’s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Sanofi Consumer Healthcare India Company Overview

Sanofi Consumer Healthcare India owns established over the counter and consumer health brands such as Combiflam and Allegra in India, following its demerger from Sanofi India‘s prescription pharma business. Understanding the business model is the first step in framing any credible Sanofi Consumer Healthcare India share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company	Sanofi Consumer Healthcare India
NSE Ticker	SANOFICONR
CMP (10 July 2026)	Rs 4,601
52 Week High	Rs 5,512
52 Week Low	Rs 3,950
Market Cap	Rs 10,597 Cr
Stock PE	41.9
Book Value	Rs 167
ROE	71.6%
ROCE	89.9%
Dividend Yield	1.63%

Where Does Sanofi Consumer Healthcare India Share Price Stand Today?

The stock currently trades about 17 percent below its 52 week high of Rs 5,512, which means the market has already tempered some of its optimism. For anyone building a Sanofi Consumer Healthcare India share price forecast, this correction matters for the Sanofi Consumer Healthcare India share price forecast starting point, because entry valuations have a large bearing on 3 year returns.

At the current price, Sanofi Consumer Healthcare India commands a market capitalisation of Rs 10,597 Cr and trades at a price to earnings multiple of 41.9. The company generates a return on equity of 71.6% and a return on capital employed of 89.9%, which places it in the category of businesses with strong return ratios. These numbers anchor the Sanofi Consumer Healthcare India share price forecast scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

Sanofi Consumer Healthcare India Share Price Forecast: Key Growth Drivers for the Next 3 Years

Four forces are likely to shape the Sanofi Consumer Healthcare India share price forecast between now and 2030, and together they explain most of the dispersion in this Sanofi Consumer Healthcare India share price forecast. Each is discussed below with its likely direction of impact.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. With strong return ratios at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Sanofi Consumer Healthcare India share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Consumption Recovery and Rural Demand Tailwinds

FMCG demand is recovering as rural incomes improve, inflation cools and government spending supports consumption. Distribution expansion and premiumisation give branded players such as Sanofi Consumer Healthcare India multiple levers to convert category growth into earnings. Sector trends are visible in the Nifty FMCG index, which serves as a useful barometer for the space.

Within the space, investors often benchmark Sanofi Consumer Healthcare India against peers such as Abbott India, Sanofi India and GlaxoSmithKline Pharmaceuticals on growth and valuations before forming a view on the Sanofi Consumer Healthcare India share price forecast.

Company Specific Catalysts

The bull case for Sanofi Consumer Healthcare India rests on brand strength in OTC pain and allergy categories, distribution reach and margin discipline as a focused consumer entity. If these play out on schedule, the Sanofi Consumer Healthcare India share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.

Macro Environment and Liquidity

The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Sanofi Consumer Healthcare India share price forecast, while global risk aversion would do the opposite to the Sanofi Consumer Healthcare India share price outlook.

Sanofi Consumer Healthcare India Share Price Forecast 2027, 2028 and 2030: Scenario Analysis

The table below presents a scenario based Sanofi Consumer Healthcare India share price forecast using compounded annual growth assumptions applied to the current market price of Rs 4,601. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.

Year	Bear Case	Base Case	Bull Case	Assumption
2027	Rs 4,950	Rs 5,450	Rs 5,900	5% to 18% CAGR on CMP
2028	Rs 5,200	Rs 6,110	Rs 6,960	5% to 18% CAGR on CMP
2030	Rs 5,730	Rs 7,660	Rs 9,690	5% to 18% CAGR on CMP

In the base case scenario of this Sanofi Consumer Healthcare India share price forecast, the 2030 level works out to roughly Rs 7,660, implying steady compounding from today’s levels. The bull case of Rs 9,690 assumes brand strength in OTC pain and allergy categories delivers ahead of expectations, while the bear case of Rs 5,730 captures a scenario where growth stalls. That is an outcome band of about 25 percent to 111 percent over the period.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Bull Case vs Bear Case for Sanofi Consumer Healthcare India Share Price

The Bull Case

The optimistic Sanofi Consumer Healthcare India share price forecast assumes brand strength in OTC pain and allergy categories, distribution reach and margin discipline as a focused consumer entity. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 9,690 by 2030.

The Bear Case

The cautious view centres on the fact that regulatory changes on OTC drug classification and competitive intensity in consumer healthcare are risks. If these pressures dominate, the Sanofi Consumer Healthcare India share price forecast would skew toward the lower band and the stock could stagnate near Rs 5,730 even by 2030, underperforming broader indices.

Key Risks That Could Change the Sanofi Consumer Healthcare India Share Price Outlook

• Execution risk: Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Sanofi Consumer Healthcare India share price forecast.
• Valuation risk: At a PE of 41.9, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.
• Sector risk: Regulatory changes on OTC drug classification and competitive intensity in consumer healthcare are risks.
• Macro risk: A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.
• Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.

Is Sanofi Consumer Healthcare India Worth Watching for the Long Term?

For long term investors, the relevant question is not just where the Sanofi Consumer Healthcare India share price forecast lands in 2030 or what any single Sanofi Consumer Healthcare India share price forecast says today, but whether the business can compound capital through cycles. The company’s positioning around brand strength in OTC pain and allergy categories gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.

Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Sanofi Consumer Healthcare India share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.

Download the Univest iOS App or Univest Android App to track Sanofi Consumer Healthcare India share price live.

Conclusion

The Sanofi Consumer Healthcare India share price forecast for the next 3 years spans Rs 5,730 to Rs 9,690 by 2030 under the scenarios discussed, with a base case near Rs 7,660. Any credible Sanofi Consumer Healthcare India share price forecast must be updated as facts change, and the path will be decided by earnings delivery, brand strength in OTC pain and allergy categories and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.

What is the Sanofi Consumer Healthcare India share price forecast for the next 3 years?

Ans. The Sanofi Consumer Healthcare India share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 5,730 in the bear case to Rs 9,690 in the bull case, with a base case near Rs 7,660, depending on earnings delivery and market conditions.

What is the Sanofi Consumer Healthcare India share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 4,950 to Rs 5,900, with a base case around Rs 5,450. This assumes compounding on the current price of Rs 4,601 and is illustrative, not a guaranteed outcome.

What is the Sanofi Consumer Healthcare India share price forecast for 2028?

Ans. The 2028 scenario range is Rs 5,200 to Rs 6,960, with the base case near Rs 6,110. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Sanofi Consumer Healthcare India?

Ans. As of 10 July 2026, Sanofi Consumer Healthcare India trades at around Rs 4,601 on the NSE, within a 52 week range of Rs 3,950 to Rs 5,512. Prices change continuously during market hours, so check live quotes before acting.

Is Sanofi Consumer Healthcare India a good stock for the long term?

Ans. Sanofi Consumer Healthcare India has a credible long term story built on brand strength in OTC pain and allergy categories, but it also carries risks since regulatory changes on OTC drug classification and competitive intensity in consumer healthcare are risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Sanofi Consumer Healthcare India share price outlook for 2030?

Ans. The Sanofi Consumer Healthcare India share price outlook for 2030 spans Rs 5,730 to Rs 9,690 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Sanofi Consumer Healthcare India share price forecast?

Ans. The main risks are execution delays, valuation compression from the current PE of 41.9, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.